ClinicalTrials.gg
Active, not recruitingNCT02888262BIOUpdated Oct 19, 2023

The Bipolar Illness Onset Study (the BIO Study)

An observational study in Bipolar Disorder, sponsored by Mental Health Services in the Capital Region, Denmark. Active, not recruiting at 1 site in Denmark. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-19.

Sponsored by Mental Health Services in the Capital Region, Denmark · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
700
Ages
16 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 49 studies in Bipolar Disorder with a site in Denmark — 13 open to participants now, 17 under way, 1 of them phase 3. Bipolar Disorder · Denmark.

Started
2016
the only one that year
Observational
7 of 49
3 open now
Primary completion
2026-12
later than 6 of 16 live
Registered
17th of 49
by date
Lead sponsor
9 of 49
Mental Health Services in the Capital Region, Denmark

Among the 49 studies in Bipolar Disorder with a site in Denmark, this one is the only one that started in 2016, is one of 7 observational ones, reaches primary completion later than 6 of the 16 other live ones, and was the 17th registered.

Bipolar Disorder

1,687 studies on the registry are indexed under Bipolar Disorder; 268 are open to participants now.

Browse Bipolar Disorder studies →

Open to participants now

13 of the 49 studies in Bipolar Disorder with a site in Denmark are open now. Recruiting first, the newest first:

8 more — sign in →

All 13 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 207 Bipolar Disorder studies recruiting now, 60 (29%) set no upper age limit and 134 (65%) stop at 75 or younger; 38 take children under 18; 51 take healthy volunteers.

This study: 16 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 49 studies in Bipolar Disorder with a site in Denmark, or all of them as a file.
02

Study summary

This longitudinal study aims to identify 1) a composite blood-based biomarker, 2) a composite electronic Smartphone-based biomarker and 3) a neurocognitive signature for bipolar disorder

Read the detailed description

The study will include 300 patients with newly diagnosed/first episode bipolar disorder, 200 healthy siblings or child family members and 100 healthy individuals without a family history of affective disorder. All individuals will be investigated with repeated blood tests, Smartphone recordings, neuropsychological tests and brain imaging during a five to ten year study period.

03

Conditions studied

  • Bipolar Disorder

Browse trials for

Keywords

  • Bipolar disorder
  • Blood
  • Smartphone
  • Brain imaging
  • Cognition
  • Neuropsychology
04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

  1. 300 patients referred to the Copenhagen Affective Disorder Clinic as newly diagnosed/first episode bipolar patients, i.e., onset of first manic or hypomanic episode or when the diagnosis of bipolar disorder is made for the first time.
  2. 200 first-generation relatives (siblings and children aged 15 to 40 years) to the recruited newly diagnosed/first episode bipolar patients.
  3. 100 age-, gender- and IQ-matched sample of healthy individuals without a first-generation family history of affective disorders recruited among blood donors from the Blood Bank at Rigshospitalet, Copenhagen, as in prior studies.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Newly diagnosed/first episode bipolar patients,
  2. First-generation relatives (siblings and children aged 15 to 40 years) to the recruited newly diagnosed/first episode bipolar patients.
  3. Age- and gender matched sample of healthy individuals without a first-generation family history of effective disorders

Exclusion criteria

Exclusion Criteria:

  1. Significant physical disorders
  2. Schizophrenia or related disorders
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
700 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Patients with bipolar disorder

    Patients with newly diagnosed bipolar disorder

  • Healthy first generation relatives

    Healthy first generation relatives to the included patients

  • Healthy individuals

    Healthy individuals without a family history of psychiatric disorders

06

What researchers measure

Primary outcomes

  1. Composite blood based biomarker

    Time frame: 5 years

Secondary outcomes

  1. Composite smartphone based biomarker including self reported and smartphone generated data

    Composite smartphone based biomarker including 1) self reported data and 2) smartphone generated data on physical activity 3) social activity and 4) voice features collected during phone calls

    Time frame: 5 years

  2. Composite neurocognitive marker including "Cold" and "Hot" cognition.

    Composite neurocognitive marker including "Cold" cognition assessed with neuropsychological tests probing verbal memory and executive function and "Hot" cognition assessed with a comprehensive computerized battery of cognitive tests probing (i) emotional processing (ii) reward processing and (iii) emotional regulation.

    Time frame: 5 years

07

Study locations

1 site
08

References and documents

Publications

  • Stanislaus S, Coello K, Kjaerstad HL, Sletved KSO, Seeberg I, Frost M, Bardram JE, Jensen RN, Vinberg M, Faurholt-Jepsen M, Kessing LV. Prevalences of comorbid anxiety disorder and daily smartphone-based self-reported anxiety in patients with newly diagnosed bipolar disorder. Evid Based Ment Health. 2021 Nov;24(4):137-144. doi: 10.1136/ebmental-2021-300259. Epub 2021 Jun 3. PubMed 34083204 ↗
  • Stanislaus S, Vinberg M, Melbye S, Frost M, Busk J, Bardram JE, Kessing LV, Faurholt-Jepsen M. Smartphone-based activity measurements in patients with newly diagnosed bipolar disorder, unaffected relatives and control individuals. Int J Bipolar Disord. 2020 Nov 2;8(1):32. doi: 10.1186/s40345-020-00195-0. PubMed 33135120 ↗
  • Stanislaus S, Vinberg M, Melbye S, Frost M, Busk J, Bardram JE, Faurholt-Jepsen M, Kessing LV. Daily self-reported and automatically generated smartphone-based sleep measurements in patients with newly diagnosed bipolar disorder, unaffected first-degree relatives and healthy control individuals. Evid Based Ment Health. 2020 Nov;23(4):146-153. doi: 10.1136/ebmental-2020-300148. Epub 2020 Aug 24. PubMed 32839276 ↗
  • Melbye SA, Stanislaus S, Vinberg M, Frost M, Bardram JE, Sletved K, Coello K, Kjaerstad HL, Christensen EM, Faurholt-Jepsen M, Kessing LV. Mood, activity, and sleep measured via daily smartphone-based self-monitoring in young patients with newly diagnosed bipolar disorder, their unaffected relatives and healthy control individuals. Eur Child Adolesc Psychiatry. 2021 Aug;30(8):1209-1221. doi: 10.1007/s00787-020-01611-7. Epub 2020 Aug 2. PubMed 32743692 ↗
  • Kessing LV, Munkholm K, Faurholt-Jepsen M, Miskowiak KW, Nielsen LB, Frikke-Schmidt R, Ekstrom C, Winther O, Pedersen BK, Poulsen HE, McIntyre RS, Kapczinski F, Gattaz WF, Bardram J, Frost M, Mayora O, Knudsen GM, Phillips M, Vinberg M. The Bipolar Illness Onset study: research protocol for the BIO cohort study. BMJ Open. 2017 Jun 23;7(6):e015462. doi: 10.1136/bmjopen-2016-015462. PubMed 28645967 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2016 (actual). Primary completion is estimated for Dec 2026, 131 months after the start.

Of 95 non-industry observational studies under Bipolar Disorder, half reached primary completion within 65 months of starting (the median), counting those still running; a quarter within 39 and three quarters within 119. This study's planned 131 months is above that.

Counting every sponsor, half of 105 studies reached it within 64 months; a quarter within 31 and three quarters within 119.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 24, 2016
First posted
Sep 2, 2016
StartActual
Jan 2016
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Oct 19, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02888262
Lead sponsor
Mental Health Services in the Capital Region, Denmark
Responsible party
Lars Vedel Kessing (Professor, MD, DMSc., Mental Health Services in the Capital Region, Denmark) — Principal investigator
First posted
Sep 2, 2016
Start date
Jan 2016
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Oct 19, 2023

Study contacts

Lars V Kessing, Professor
principal investigator · Psychiatric Center Copenhagen

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion